Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review

  • ID: 4284981
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4

Atara Biotherapeutics Inc (Atara) is a clinical research company that develops immunotherapies for cancers, autoimmune and severe viral infectious diseases. The company offers clinical stage T-cell product candidates such as ATA129, for the treatment of rituximab-refractory epstein-barr virus associated post-transplant lymphoproliferative disorder after hematopoietic cell transplant and solid organ transplant; ATA188, for the treatment of multiple sclerosis; ATA520, a clinical trial product targeting cancers expressing the antigen wilms tumor 1; and ATA230, for refractory cytomegalovirus. Its other pipeline candidates include STM 434 for the treatment of ovarian cancer and other solid tumors; preclinical stage compounds in-licensed from Amgen; and ATA 845 for cachexia in cancer patients. Atara is headquartered in South San Francisco, California, the US.

Atara Biotherapeutics Inc Key Recent Developments

Feb 27, 2018: Atara Biotherapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Progress
Feb 21, 2018: Atara Biotherapeutics Announces Chief Financial Officer Intention to Retire in April 2018
Jan 08, 2018: ArTara Therapeutics Announces Addition of Randall Marshall, MD as Chief Medical Officer
Nov 09, 2017: Atara Biotherapeutics Announces Third Quarter 2017 Financial Results and Recent Highlights
Aug 22, 2017: Atara Biotherapeutics expands leadership team with the appointment of Dr. Kanya Rajangam as Senior Vice President and Chief Medical Officer

This comprehensive SWOT profile of Atara Biotherapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Atara Biotherapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Atara Biotherapeutics Inc - Key Information
  • Atara Biotherapeutics Inc - Overview
  • Atara Biotherapeutics Inc - Key Employees
  • Atara Biotherapeutics Inc - Key Employee Biographies
  • Atara Biotherapeutics Inc - Key Operational Heads
  • Atara Biotherapeutics Inc - Major Products and Services
  • Atara Biotherapeutics Inc - History
  • Atara Biotherapeutics Inc - Company Statement
  • Atara Biotherapeutics Inc - Locations And Subsidiaries
  • Atara Biotherapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Atara Biotherapeutics Inc - Business Description
  • Atara Biotherapeutics Inc - Corporate Strategy
  • Atara Biotherapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Atara Biotherapeutics Inc - Strengths
  • Atara Biotherapeutics Inc - Weaknesses
  • Atara Biotherapeutics Inc - Opportunities
  • Atara Biotherapeutics Inc - Threats
  • Atara Biotherapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Atara Biotherapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Atara Biotherapeutics Inc, Key Information
  • Atara Biotherapeutics Inc, Key Ratios
  • Atara Biotherapeutics Inc, Share Data
  • Atara Biotherapeutics Inc, Major Products and Services
  • Atara Biotherapeutics Inc, History
  • Atara Biotherapeutics Inc, Key Employees
  • Atara Biotherapeutics Inc, Key Employee Biographies
  • Atara Biotherapeutics Inc, Key Operational Heads
  • Atara Biotherapeutics Inc, Other Locations
  • Atara Biotherapeutics Inc, Subsidiaries
  • Atara Biotherapeutics Inc, Key Manufacturing facilities
  • Atara Biotherapeutics Inc, Key Competitors
  • Atara Biotherapeutics Inc, SWOT Analysis
  • Atara Biotherapeutics Inc, Ratios based on current share price
  • Atara Biotherapeutics Inc, Annual Ratios
  • Atara Biotherapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Atara Biotherapeutics Inc, Performance Chart
  • Atara Biotherapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown